BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Prognosis
16 results:

  • 1. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.
    Alahmari AA; Chaubey AH; Jonnakuti VS; Tisdale AA; Schwarz CD; Cornwell AC; Maraszek KE; Paterson EJ; Kim M; Venkat S; Gomez EC; Wang J; Gurova KV; Yalamanchili HK; Feigin ME
    RNA; 2024 Feb; 30(3):281-297. PubMed ID: 38191171
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association Between a History of Breast cancer and Decreased Thyroid cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Miyagawa Y; Kitazawa M; Tokumaru S; Nakamura S; Koyama M; Yamamoto Y; Miyazaki S; Hondo N; Soejima Y
    Oncology; 2024; 102(2):114-121. PubMed ID: 37699374
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
    Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
    Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
    Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
    Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
    [No Abstract]    [Full Text] [Related]  

  • 7. Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.
    Qian H; Yuan D; Bao J; Liu F; Zhang W; Yang X; Han G; Huang J; Sheng H; Yu H
    Medicine (Baltimore); 2019 Mar; 98(10):e14608. PubMed ID: 30855445
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Postoperative chemotherapy had no prognostic effect on early-staged young ovarian cancer with unilateral resection.
    Zhang X; Wang S; Zhao S; Sun Y; Yang G
    Cancer Med; 2018 Nov; 7(11):5488-5496. PubMed ID: 30306725
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
    Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
    Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
    Cancer Biomark; 2016; 17(4):419-425. PubMed ID: 27802193
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Influence of Cyst Emptying, Lymph Node Resection and Chemotherapy on Survival in Stage IA and IC1 Epithelial Ovarian cancer.
    Rosendahl M; Mosgaard BJ; Høgdall C
    Anticancer Res; 2016 Oct; 36(10):5373-5379. PubMed ID: 27798901
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. bcl9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.
    Hallas C; Phillipp J; Domanowsky L; Kah B; Tiemann K
    BMC Cancer; 2016 Aug; 16():648. PubMed ID: 27539223
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.
    Bakrin N; Bereder JM; Decullier E; Classe JM; Msika S; Lorimier G; Abboud K; Meeus P; Ferron G; Quenet F; Marchal F; Gouy S; Morice P; Pomel C; Pocard M; Guyon F; Porcheron J; Glehen O;
    Eur J Surg Oncol; 2013 Dec; 39(12):1435-43. PubMed ID: 24209430
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
    Grisham RN; Iyer G; Garg K; Delair D; Hyman DM; Zhou Q; Iasonos A; Berger MF; Dao F; Spriggs DR; Levine DA; Aghajanian C; Solit DB
    Cancer; 2013 Feb; 119(3):548-554. PubMed ID: 22930283
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
    Netinatsunthorn W; Hanprasertpong J; Dechsukhum C; Leetanaporn R; Geater A
    BMC Cancer; 2006 Apr; 6():90. PubMed ID: 16606472
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Cold nodules of the thyroid. Reevaluation of surgical excision on the basis of a new group of 607 patients(author's transl)].
    Melliere D; Danis RK; Lasry G
    Nouv Presse Med; 1979 Apr; 8(17):1399-402. PubMed ID: 482111
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.